- Strengthens Position as Expert in Diabetes Management
- Steps up Preparation for Commercial Launch of Uni-E4
HONG KONG, CHINA - Media OutReach - 4 May 2017 - Uni-Bio Science Group Limited ("Uni-Bio Science" or the "Group"; HKSE: 690) today announced that, with the exclusive global rights to manufacture and commercialize Mitiglinide acquired...
More...
